[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 14, 1994

Efficacy of BCG Vaccine

Author Affiliations

Montefiore-Rikers Island Health Service East Elmhurst, NY

JAMA. 1994;272(10):765. doi:10.1001/jama.1994.03520100029014
Abstract

To the Editor.  —In their meta-analysis of the published literature on BCG vaccine, Dr Colditz and colleagues1 attempt to summarize BCG's protective effect by building a statistical model with variables for geographic latitude and validity scores. Geographic latitude is a variable without biological cogency (though some stretches have been attempted), yet it is retained in the model because it conveniently explains 41% of the variability. I suspect that its primary function is to attenuate the impact of the largest, most recent, and most damaging prospective study on the thesis that BCG vaccine is effective—the Madras study.2 We should note that the Madras study is larger than the next three studies in size combined1(Table 1) and found no protective effect. The Madras study was felt necessary at the time to finally prove the utility of BCG vaccine, yet its results are ignored without a call for additional study.

First Page Preview View Large
First page PDF preview
First page PDF preview
×